MAPT and Alzheimer disease: These results are consistent with what other authors have already shown regarding the pathological accumulation of Aβ and phosphorylated tau (p-tau), which are the typical signs of AD in the eyes of patients with AD and the eyes of transgenic mouse models of this disease.